Immunocompetence to assess nutritional status in eating disorders

References

• Chandra RK. Iron-zinc, immune response and infection. In: Nutrition, Immunity and Infection Disease in Infants and Children. Nestle Nutrition Workshop (Volume 45).Tontisirin K, Suskind R (Eds). Nestle Nutrition Services, 201–212 (2001).
   Google Scholar
• Heys SD, Simpson WG, Eremin O. Surgical Nutrition. In: Emergency Surgery and Critical Care. A Companion to Specialist Surgical Practice. Paterson-Brown S (Ed.). WB Saunders Co, PA, USA, 55–120 (1997).
   Google Scholar
• Chandra RK. Nutrition and immunity: lessons from the past and new insights into the future. Am. J. Clin. Nutr.53, 1087–1101 (1991).
   PubMed Web of Science ®Google Scholar
• Chandra RK. Nutrition and the immune system: an introduction. Am. J. Clin. Nutr.66, S460–S463 (1997).
   PubMed Web of Science ®Google Scholar
• Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int. J. Eat. Disord.34(4), 383–396 (2003).
   PubMed Web of Science ®Google Scholar
• Marcos A. Eating disorders: a situation of malnutrition with peculiar changes in the immune system. Eur. J. Clin. Nutr.54(S1), S61–S64 (2000).
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington, DC, USA (1994).
   Google Scholar
• Silber TJ, Chan M. Immunologic fluorometric studies in adolescents with anorexia nervosa. Int. J. Eat. Disord.19, 415–418 (1996).
   PubMedGoogle Scholar
• Cason J, Ainley CC, Volstencroft RA, Norton KRW, Thompson RPH. Cell mediated immunity in anorexia nervosa. Clin. Exp. Immunol.64, 370–375 (1986).
   PubMedGoogle Scholar
• Varela P, Marcos A, Muñoz.Velez A, Santacruz I, Requejo A. Delayed hypersensitivity skin test in anorexia nervosa and bulimia. Med. Sci. Res.16, 1135 (1988).
   Google Scholar
• Marcos A, Varela P, Santacruz I, Muñoz-Velez A, Morandé G. Nutritional status and immunocompetence in eating disorders. A comparative study. Eur. J. Clin. Nutr.47, 787–793 (1993).
   PubMed Web of Science ®Google Scholar
• Marcos A, Varela P, Santacruz I, Muñoz-Vélez A. Evaluation of immunocompetence and nutritional status in patients with bulimia nervosa. Am. J. Clin. Nutr.57, 65–69 (1993).
   PubMed Web of Science ®Google Scholar
• Marcos A, Varela P, Toro O, Nova E, López-Vidriero I, Morandé G. Evaluation of nutritional status by immunological assessment in bulimia nervosa. Influence of BMI and vomiting episodes. Am. J. Clin. Nutr.66S, S491–S497 (1997).
   Google Scholar
• Van de Berg BC, Malghem J, Devuyst O, Maldague BE, Lambert MJ. Anorexia nervosa: correlation between MR appearance of bone marrow and severity of disease. Radiology193, 859–864 (1994).
   PubMedGoogle Scholar
• Brambilla F, Ferrari E, Brunetta M et al. Immunoendocrine aspects of anorexia nervosa. Psychiatry Res.62, 97–104 (1996).
   PubMed Web of Science ®Google Scholar
• Mustafa A, Ward A, Teasure J, Peakman M. T lymphocyte subpopulations in anorexia nervosa and refeeding. Clin. Immunol. Immunopath.82, 282–289 (1997).
   PubMedGoogle Scholar
• Allende LM, Corell A, Manzanares J et al. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology94, 543–551 (1998).
   PubMedGoogle Scholar
• Fink S, Eckert E, Mitchell J, Crosby R, Pomeroy C. T-lymphocyte subsets in patients with abnormal body weight: longitudinal studies in anorexia nervosa and obesity. Int. J. Eat. Disord.20, 295–305 (1996).
   PubMedGoogle Scholar
• do Carmo I, Palma-Carlos ML, Melo A et al. [Characterization of leukocytes, lymphocytes and lymphocyte subsets in eating disorders] Allerg. Immunol. (Paris).29(9), 261–268 (1997).
   PubMedGoogle Scholar
• Nagata T, Kiriike N, Tobitani W, Kawarada Y, Matsunaga H, Yagamami S. Lymphocyte subset, lymphocyte proliferative response and soluble interleukin-2 receptor in anorexic patients. Biol. Psychiatry45, 471–474 (1999).
   PubMedGoogle Scholar
• Nova E, Varela P, Toro O et al. Dietary intake and anthropometry in anorexia nervosa patients undergoing rehabilitation treatment. A one-year follow-up study. Eur. J. Clin. Nutr.55, 547–554 (2001).
   PubMed Web of Science ®Google Scholar
• Marcos A, Varela P, Toro O et al. Interactions between nutrition and immunity in anorexia nervosa. A one year follow-up. Am. J. Clin. Nutr.S66, S485–S490 (1997).
   Google Scholar
• Golla AG, Larson LA, Anderson CF, Lucas AR, Wilson WR, Tomasi TB. Immunological assessment of patients with anorexia nervosa. Am. J. Clin. Nutr.34, 2756–2762 (1981).
   PubMed Web of Science ®Google Scholar
• Polack E, Nahmod VE, Emeric Sauval E et al. Low lymphocyte interferon-γ production and variable proliferative response in anorexia nervosa patients. J. Clin. Immunol.13, 445–451 (1993).
   PubMedGoogle Scholar
• Dally P. Anorexia nervosa. William Heinemann Medical Books Ltd, London, UK (1969).
   Google Scholar
• Bowers TK, Eckert E. Leukopenia in anorexia nervosa: Lack of risk of increased infection. Arch. Intern. Med.138, 1520–1523 (1978).
   PubMedGoogle Scholar
• Wade S, Bleiberg F, Mossé A et al. Thymulin (Zn-Facteur Thymique Serique) activity in anorexia nervosa patients. Am. J. Clin. Nutr.42, 275–280 (1985).
   PubMedGoogle Scholar
• Nova E, Samartín S, Gómez S, Morandé G, Marcos A. The adaptive response of the immune system to the particular malnutrition of eating disorders. Eur. J. Clin. Nutr.56(Suppl.), S34–S37 (2002).
   PubMed Web of Science ®Google Scholar
• Marcos A. The immune system in eating disorders: An overview. Nutrition13, 853–862 (1997).
   PubMed Web of Science ®Google Scholar
• Hart BL. Behavioral adaptations to pathogens and parasites: five strategies. Neurosci. Biobehav. Rev.14, 273–294 (1990).
   PubMed Web of Science ®Google Scholar
• Birmingham CL, Hodgson DM, Fung J et al. Reduced febrile response to bacterial infection in anorexia nervosa patients. Int. J. Eat. Disord.34, 269–272 (2003).
   PubMedGoogle Scholar
• Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol. Metab. Clin. North. Am.31(1), 173–189 (2002).
   PubMed Web of Science ®Google Scholar
• Bachmann K, Arieli A, Burger AG, Chinet AE. Triiodothyronine (T3)-induced thermogenesis: altered T3-efficiency in tissues from fed, starved, and refed hypothyroid rats. Endocrinology117(3), 1084–1089 (1985).
   PubMedGoogle Scholar
• Grimble RF. Malnutrition and the immune response. 2. Impact of nutrients on cytokine biology in infection. Trans. R. Soc. Trop. Med. Hyg.88, 615–619 (1994).
   PubMedGoogle Scholar
• Holden RJ, Pakula IS. The role of tumour necrosis factor-α in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med. Hypothesis47, 423–438 (1996).
   PubMed Web of Science ®Google Scholar
• Holden RJ, Pakula IS. Tumor necrosis factor-α: is there a continuum of liability between stress, anxiety states and anorexia nervosa? Med. Hypothesis52, 155–162 (1999).
   PubMedGoogle Scholar
• Emeric-Sauval E, Polack E, Bello M et al. Anorexia nervosa y bulimia – un modelo para el estudio de las interaciones immunoneuroendocrinas en respecto al CRH humano. Rev. Argent. Endocrinol. Metab.26, 72–73 (1989).
   Google Scholar
• Mitchell JE, Eckert E, Pomeroy C. The role of cytokines in anorexia nervosa. Neuropsychopharmacology10, S206 (1994) (Abstract).
   Google Scholar
• Pomeroy C, Eckert E, Shuxian H et al. Role of interleukine-6 and transforming growth factor-α in anorexia nervosa. Soc. Biol. Psychiatry36, 836–839 (1994).
   PubMedGoogle Scholar
• Nakai Y, Hamagaki S, Tagaki R, Taniguchi A, Kurimoto F. Plasma concentrations of tumor necrosis factor α (TNF-α) and soluble TNF receptors in patients with anorexia nervosa. J. Clin. Endocrinol. Metab.84, 1226–1228. (1999).
   PubMedGoogle Scholar
• Vaisman N, Barak Y, Hahn T, Karov Y, Malach L, Barak V. Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatr. Res.40, 108–111 (1996).
   PubMed Web of Science ®Google Scholar
• Brambilla F, Bellodi L, Brunetta M, Perna G. Plasma concentrations of interleukin-1 β, interleukin-6 and tumor necrosis factor-α in anorexia and bulimia nervosa. Psychoneuroendocrinology23, 439–447 (1998).
   PubMedGoogle Scholar
• Brambilla F, Monti D, Franceschi C. Plasma concentrations of interleukin-1-β, interleukin 6 and tumor necrosis factor-α, and of their soluble receptors and receptor antagonist in anorexia nervosa.Psychiatry Res.103, 107–114 (2001).
   PubMedGoogle Scholar
• Monteleone P, Maes M, Fabrazzo M et al. Immunoendocrine findings in patients with eating disorders. Neuropsychobiology40, 115–120 (1999).
   PubMed Web of Science ®Google Scholar
• Nagata T, Tobitani W, Kiriike N, Iketani T, Yamagami S. Capacity to produce cytokines during weight restoration in patients with anorexia nervosa. Psychosom. Med.61, 371–377 (1999).
   PubMed Web of Science ®Google Scholar
• Corcos M, Guilbaud O, Chaouat G et al. Cytokines and anorexia nervosa. Psychosom. Med.63, 502–504 (2001).
   PubMedGoogle Scholar
• Schattner A, Tepper R, Steinbock M, Vaisman N, Hahn T, Schonfeld A. TNF, interferon-γ, and cell-mediated cytotoxicity in anorexia nervosa; effect of refeeding. J. Clin. Lab. Immunol.32, 183–184 (1990).
   PubMedGoogle Scholar
• Limone P, Biglino A, Bottino F et al. Evidence for a positive correlation between serum cortisol levels and IL-1β production by peripheral mononuclear cells in anorexia nervosa. J. Endocrinol. Invest.23, 422–427 (2000).
   PubMedGoogle Scholar
• Nova E, Gómez-Martínez S, Morandé G, Marcos A. Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa. Brit. J. Nutr.88, 183–188 (2002).
   PubMedGoogle Scholar
• Paez Pereda M, Perez Castro C, Costas M et al. Glucocorticoids inhibit the autoregulatory induction of interleukin-1 in monocytes after endotoxin stimulation. Neuroimmunomodulation3, 227–232 (1996).
   PubMedGoogle Scholar
• Yirmiya R, Chiappelli F, Tio DL, Tritt SH, Taylor AN. Effects of prenatal alcohol and pair feeding on lipopolysaccharide-induced secretion of TNF-α and corticosterone. Alcohol15, 327–335 (1998).
   PubMedGoogle Scholar
• Corcos M, Guilbaud O, Paterniti S et al. Involvement of cytokines in eating disorders: a critical review of the human literature.Psychoneuroendocrinology28, 229–249 (2003).
   PubMed Web of Science ®Google Scholar
• Bessler H, Karp L, Notti I et al. Cytokine production in anorexia nervosa. Clin. Neuropharmacol.16, 237–243 (1993).
   PubMedGoogle Scholar
• Licinio J, Litsvak S, Altemus ME et al. Serum and CSF interleukin-1 in bulimia nervosa. Biol. Psychiatry27(Suppl. 9A), 147A (1990) (Abstract).
   Google Scholar
• Licinio J, Altemus ME, Wong M, Gold PW. Circulating levels of interleukin-2 in patients with anorexia nervosa. Biol. Psychiatry29 (Suppl. 9A), 56A (1991) (Abstract).
   Google Scholar
• Savendhal L, Underwood LE. Decreased interleukin-2 production from cultured peripheral blood mononuclear cells in human acute starvation. J. Clin. Endocrinol. Metab.82, 1177–1180 (1997).
   PubMedGoogle Scholar
• Shintani F, Kanba S, Nakaki T et al. Interleukin-1 β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci.13, 3574–3581 (1993).
   PubMed Web of Science ®Google Scholar
• Smagin GN, Swiergiel AH, Dunn AJ. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology21, 83–93 (1996).
   PubMedGoogle Scholar
• McCarthy HD, Dryden S, Williams G. Interleukin-1 β induced anorexia and pyrexia in rats: relationship to hypothalamic neuropeptide Y. Am. J. Physiol.269, E852–E857 (1995).
   Google Scholar
• Reyes TM, Sawchenko PE. Is the arcuate nucleus involved in cytokine-induced anorexia? Soc. Neurosci. Abstr.26, 4413 (2000).
   Google Scholar
• Konsman JP, Dantzer R. How the immune and nervous systems interact during disease-associated anorexia. Nutrition17, 664–668 (2001).
   PubMed Web of Science ®Google Scholar
• Kahl KG, Kruse N, Rieekmann P, Schmidt MH. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychoneuroendocrinol.29, 13–20 (2004).
   PubMedGoogle Scholar
• Schattner A, Steinbock M, Tepper R, Schonfeld A, Vaisman N, Hahn T. Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa. Clin. Exp. Immunol.79, 62–66 (1990).
   PubMedGoogle Scholar
• Vaisman N, Hahn T. Tumor necrosis factor-α and anorexia – cause or effect? Metabolism40, 720–723 (1991).
   PubMedGoogle Scholar
• Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism42(5), 581–584 (1993).
   PubMed Web of Science ®Google Scholar
• van den Bergh P, Dobber R, Ramlal S, Rozing J, Nagelkerken L. Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cell Immunol.154(1), 109–122 (1994)
   PubMedGoogle Scholar
• Brambilla F, Brunetta M, Peirone A, Perna G, Sacerdote P, Manfredi B, Panerai AE. T-lymphocyte cholecystokinin-8 and β-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Res.59(1–2), 43–50 (1995)
   PubMedGoogle Scholar
• Staurenghi AH, Masera RG, Prolo P et al. Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa. Psychoneuroendocrinology22(8), 575–590 (1997)
   PubMedGoogle Scholar
• Kaye WH, Weltzin TE. Neurochemistry of bulimia nervosa. J. Clin. Psychiatry52(S), 21–28 (1991)
   PubMedGoogle Scholar
• Khan NA, Poisson JP. 5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation. J. Neuroimmunol.99, 53–60 (1999).
   PubMed Web of Science ®Google Scholar
• Marazziti D, Dell’osso B, Baroni S et al. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients. Pharmacopsychiatry39(1), 35–38 (2006).
   PubMedGoogle Scholar
• Masuda A, Shibasaki T, Hotta M, Suematsu H, Shizume K. Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion. J. Endocrinol. Invest.11(4), 297–302 (1988).
   PubMed Web of Science ®Google Scholar
• Lanfranco F, Gianotti L, Destefanis S, Arvat E, Ghigo E, Camanni F. [Endocrine abnormalities in anorexia nervosa]. Minerva Endocrinol.28(2), 169–180 (2003).
   PubMedGoogle Scholar
• Baigent SM, Lowry PJ. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J. Mol. Endocrinol.25(1), 43–52 (2000).
   PubMed Web of Science ®Google Scholar
• Klein JR. Physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tissues other than the thyroid. Autoimmunity36(6–7), 417–421 (2003).
   PubMed Web of Science ®Google Scholar
• Meazza C, Pagani S, Travaglino P, Bozzola M. Effect of growth hormone (GH) on the immune system. Pediatr. Endocrinol. Rev.1 (S3), 490–495 (2004).
   PubMedGoogle Scholar
• Monteleone P, Di Lieto A, Tortorella A, Longobardi N, Maj M. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge eating disorder: Relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Res.94, 121–129 (2000).
   PubMedGoogle Scholar
• Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur. Cytokine Netw.11, 7–13 (2000).
   PubMed Web of Science ®Google Scholar
• Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol.174(6), 3137–3142 (2005).
   PubMed Web of Science ®Google Scholar
• Loffreda S, Yang SQ, Lin HZ et al. Leptin regulates proinflammatory immune responses, FASEB J.12, 57–65 (1998).
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines and inflammation. J. Allergy and Clin. Immunol.115(5), 911–919. (2005).
   PubMed Web of Science ®Google Scholar
• Herpertz S, Norbert A, Richard W et al. Longitudinal changes of circadian leptin, insulin and cortisol plasma levels and their correlation during refeeding in patients with anorexia nervosa. Eur. J. Endocr.142, 373–379 (2000).
   PubMed Web of Science ®Google Scholar
• Pellegrino TC, Bayer BM. Modulation of immune cell function following fluoxetine administration in rats. Pharmacol. Biochem. Behav.59, 151–157 (1998).
   PubMedGoogle Scholar
• Pawlikowski M, Lyson K, Kunert-Radek J, Stepien H. Effect of benzodiazepines on the proliferation of mouse spleen lymphocytes in vitro. J. Neural Transmis.73, 161–166 (1988).
   PubMedGoogle Scholar
• Yirmiya R, Pollak Y, Barak O et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology24, 531–544 (2001).
   PubMed Web of Science ®Google Scholar
• Fruscella P, Sottocorno M, Di Braccio M et al. 1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandin E2 production. Pharmacol. Res.43, 445–452 (2001).
   PubMed Web of Science ®Google Scholar
• Nawrocka W, Sztuba B, Zimecki M. Synthesis and immunotropic properties of 5-substituted 1,5-benzodiazepin-2-ones derivatives in cultures of human peripheral blood cells, Part III. Archiv der Pharmazie334, 11–16 (2001).
   PubMed Web of Science ®Google Scholar
• Kim Y, Michael AF. Hypocomplementemia in anorexia nervosa. J. Pediatr.87(4), 582–585 (1975).
   PubMedGoogle Scholar
• Pomeroy C, Mitchell J, Eckert E, Raymond N, Crosby R, Dalmasso AP. Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity. Clin. Exp. Immunol.108, 507–515 (1997).
   PubMedGoogle Scholar
• Nova E, Lopez-Vidriero I, Varela P, Toro O, Casas J, Marcos A. Indicators of nutritional status in restricting-type anorexia nervosa patients. A one-year follow-up study. Clin. Nutr.23, 1353–1359 (2004).
   PubMedGoogle Scholar
• Nova E, Toro O, Varela P, López-Vidriero I, Morandé G, Marcos A. Effects of a nutritional intervention with yogurt on lymphocyte subsets and cytokine production capacity in anorexia nervosa patients. Eur. J. Nutr.47 (2006) (In press).
   Google Scholar
• Guerre-Millo M. Adipose tissue hormones. J. Endocrinol. Invest.25, 855–861 (2002).
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol.148, 293–300 (2003).
   PubMed Web of Science ®Google Scholar
• Yokota T, Oritani K, Takahashi I et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood96, 1723–1732 (2000).
   PubMed Web of Science ®Google Scholar
• Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm. Metab. Res.35(6), 337–342 (2003).
   PubMedGoogle Scholar
• Pannacciulli N, Vettor R, Milan G et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J. Clin. Endocrinol. Metab.88, 1748–1752 (2003).
   PubMed Web of Science ®Google Scholar
• Patel L, Buckels AC, Kinghorn IJ et al. Resistin is expressed in human macrophages and directly regulated by PPAR γ activators. Biochem. Biophys. Res. Commun.300(2), 472–476 (2003).
   PubMed Web of Science ®Google Scholar
• Sokol MS. Infection-triggered anorexia nervosa in children: clinical description of four cases. J. Child. Adolesc. Psychopharmacol.10, 133–145 (2000).
   PubMed Web of Science ®Google Scholar
• Sokol MS, Ward PE, Tamiya H, Kondo DG, Houston D, Zabriskie JB. D8/17 expression on B lymphocytes in anorexia nervosa. Am. J. Psychiatry159, 1430–1432 (2002).
   PubMed Web of Science ®Google Scholar
• Fetissov SO, Harro J, Jaanisk M et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc. Natl Acad. Sci. USA (2005) (Epub ahead of print).
   PubMedGoogle Scholar
• Hinney A, Friedel S, Remschmidt H, Hebebrand J. Genetic risk factors in eating disorders. Am. J. Pharmacogenomics4(4), 209–223 (2004).
   PubMedGoogle Scholar
• Ando T, Ishikawa T, Kawamura N et al. Analysis of tumor necrosis factor-α gene promoter polymorphisms in anorexia nervosa. Psychiatr. Genet.11(3), 161–164 (2001).
   Google Scholar
• Ribases M, Gratacor M, Fernandez-Aranda F et al. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum. Mol. Genet.13(12), 1205–1212 (2004).
   PubMed Web of Science ®Google Scholar
• Marcos A, Nova E, Lopez-Varela S. The immune system in eating disorders. In: Gut Flora, Nutrition, Immunity and Health. Fuller R, Perdigon G (Eds). Blackwell Publishing, Oxford, UK, 137–154 (2003).
   Google Scholar